Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan W A Smit

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Pharmacogenomics|September 12, 2002
Genetically defined pancreatic beta cell failureJan W A Smit, Michaela Diamant
Pharmacogenomics|April 23, 2004
Genetically defined hyperlipidemiaJan W A Smit, Michaela Diamant
European Journal of Nuclear Medicine and Molecular Imaging|March 3, 2004
Indium-111 octreotide scintigraphy for the detection of non-functioning metastases from differentiated thyroid cancer: diagnostic and prognostic valueMarcel P M Stokkel, Robbert B Verkooijen, Jan W A Smit
Clinical Endocrinology|April 10, 2002
Postoperative persistent thyrotrophin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegalyNienke R Biermasz, Jan W A Smit, Hans van Dulken, et al.
Nuclear Medicine Communications|June 23, 2004
Six month follow-up after 111In-DTPA-octreotide therapy in patients with progressive radioiodine non-responsive thyroid cancer: a pilot studyMarcel P M Stokkel, Robbert B T Verkooijen, Hanneke Bouwsma, et al.
Mathematical Biosciences|February 1, 2014
A novel minimal mathematical model of the hypothalamus-pituitary-thyroid axis validated for individualized clinical applicationsSimon L Goede, Melvin Khee-Shing Leow, Jan W A Smit, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 11, 2012
[Should subclinical hypothyroidism in older persons be treated?]Wendy P J den Elzen, Jan W A Smit, Simon P Mooijaart, et al.
European Journal of Endocrinology|November 30, 2006
The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancerRobbert B T Verkooijen, Jan W A Smit, Johannes A Romijn, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 7, 2005
Intravenous octreotide test predicts the long term outcome of treatment with octreotide-long-acting repeatable in active acromegalyNienke R Biermasz, Alberto M Pereira, Jan W A Smit, et al.
The Journal of Clinical Endocrinology and Metabolism|March 3, 2005
Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of lifeNienke R Biermasz, Alberto M Pereira, Jan W A Smit, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Pharmacogenomics|September 12, 2002
Genetically defined pancreatic beta cell failureJan W A Smit, Michaela Diamant
Pharmacogenomics|April 23, 2004
Genetically defined hyperlipidemiaJan W A Smit, Michaela Diamant
European Journal of Nuclear Medicine and Molecular Imaging|March 3, 2004
Indium-111 octreotide scintigraphy for the detection of non-functioning metastases from differentiated thyroid cancer: diagnostic and prognostic valueMarcel P M Stokkel, Robbert B Verkooijen, Jan W A Smit
Clinical Endocrinology|April 10, 2002
Postoperative persistent thyrotrophin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegalyNienke R Biermasz, Jan W A Smit, Hans van Dulken, et al.
Nuclear Medicine Communications|June 23, 2004
Six month follow-up after 111In-DTPA-octreotide therapy in patients with progressive radioiodine non-responsive thyroid cancer: a pilot studyMarcel P M Stokkel, Robbert B T Verkooijen, Hanneke Bouwsma, et al.
Mathematical Biosciences|February 1, 2014
A novel minimal mathematical model of the hypothalamus-pituitary-thyroid axis validated for individualized clinical applicationsSimon L Goede, Melvin Khee-Shing Leow, Jan W A Smit, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 11, 2012
[Should subclinical hypothyroidism in older persons be treated?]Wendy P J den Elzen, Jan W A Smit, Simon P Mooijaart, et al.
European Journal of Endocrinology|November 30, 2006
The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancerRobbert B T Verkooijen, Jan W A Smit, Johannes A Romijn, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 7, 2005
Intravenous octreotide test predicts the long term outcome of treatment with octreotide-long-acting repeatable in active acromegalyNienke R Biermasz, Alberto M Pereira, Jan W A Smit, et al.
The Journal of Clinical Endocrinology and Metabolism|March 3, 2005
Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of lifeNienke R Biermasz, Alberto M Pereira, Jan W A Smit, et al.
Pageof 7